Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neisseria meningitidis group B outer membrane proteins (OMPs) are key components of the bacterial cell envelope and play crucial roles in nutrient transport, host-pathogen interactions, and immune evasion. These proteins, particularly PorA and PorB, are major targets for vaccine development due to their surface exposure and immunogenicity. OMV-based vaccines containing these proteins have shown efficacy but require careful selection/matching of antigen variants for broad coverage.
Antibody-mediated bacterial killing, complement activation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neisseria meningitidis Group B Outer Membrane Protein (MenB OMP).